Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients?

Podobne zapisy

• Pembrolizumab as first-line treatment for metastatic uveal melanoma
  od: Rossi, Ernesto, i wsp.
  Wydane: (2019)
• An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer
  od: Afzal, Muhammad Zubair, i wsp.
  Wydane: (2019)
• First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
  od: Zhou, Yixin, i wsp.
  Wydane: (2019)
• Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina
  od: Wurcel, Victoria, i wsp.
  Wydane: (2021)
• Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
  od: Irina Surovtsova, i wsp.
  Wydane: (2025-12-01)